Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

The effects of expressive writing intervention in cancer patients and survivors: A rapid umbrella review

View through CrossRef
Objectives: Numerous primary studies and systematic reviews, both with and without meta-analyses, examined the effects of expressive writing intervention (EWI), yielding mixed and inconsistent findings. The purpose of this review was to assess the effects of EWI on health outcomes in cancer patients using systematic reviews with or without meta-analyses. Materials and Methods: Google Scholar, Google, and Yahoo search engines and the Cochrane databases of systematic reviews published between 1986 and October 2019 were used to conduct the searches. Five studies met all of the criteria for inclusion. According to the AMSTAR tool, 80% of the included studies achieved a moderate level of methodological quality, while the remaining 20% achieved a low level of methodological quality. Results: There were no consistent or robust findings regarding expressive writing effects, with some studies (40%, n = 2) indicating that expressive writing has no general effectiveness. In comparison, others (40%, n = 2) indicated that expressive writing affects only physical health outcomes, and only one study (20%, n = 1) indicated that expressive writing has a general effect. In addition, several studies (40%, n = 2) discovered a moderating effect. Conclusion: In summary, the findings of this narrative overview indicate that there are mixed or inconsistent findings and several moderators regarding expressive writing effects in the cancer population, implying that substantial clinical heterogeneity and deviation from Pennebaker and Beal’s, 1986, initial experiment, as well as some moderating variables, may account for this finding. Thus, future primary and review studies should employ a more rigorous methodology and greater homogeneity, notably similar to that of Pennebaker and Beal’s original study in 1986, to replicate their initial findings.
Title: The effects of expressive writing intervention in cancer patients and survivors: A rapid umbrella review
Description:
Objectives: Numerous primary studies and systematic reviews, both with and without meta-analyses, examined the effects of expressive writing intervention (EWI), yielding mixed and inconsistent findings.
The purpose of this review was to assess the effects of EWI on health outcomes in cancer patients using systematic reviews with or without meta-analyses.
Materials and Methods: Google Scholar, Google, and Yahoo search engines and the Cochrane databases of systematic reviews published between 1986 and October 2019 were used to conduct the searches.
Five studies met all of the criteria for inclusion.
According to the AMSTAR tool, 80% of the included studies achieved a moderate level of methodological quality, while the remaining 20% achieved a low level of methodological quality.
Results: There were no consistent or robust findings regarding expressive writing effects, with some studies (40%, n = 2) indicating that expressive writing has no general effectiveness.
In comparison, others (40%, n = 2) indicated that expressive writing affects only physical health outcomes, and only one study (20%, n = 1) indicated that expressive writing has a general effect.
In addition, several studies (40%, n = 2) discovered a moderating effect.
Conclusion: In summary, the findings of this narrative overview indicate that there are mixed or inconsistent findings and several moderators regarding expressive writing effects in the cancer population, implying that substantial clinical heterogeneity and deviation from Pennebaker and Beal’s, 1986, initial experiment, as well as some moderating variables, may account for this finding.
Thus, future primary and review studies should employ a more rigorous methodology and greater homogeneity, notably similar to that of Pennebaker and Beal’s original study in 1986, to replicate their initial findings.

Related Results

Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Abstract Introduction Cancer patients face a venous thromboembolism (VTE) risk that is up to 50 times higher compared to individuals without cancer. In 2010, direct oral anticoagul...
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Abstract The Physical Activity Guidelines for Americans (Guidelines) advises older adults to be as active as possible. Yet, despite the well documented benefits of physical a...
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Abstract A cervical rib (CR), also known as a supernumerary or extra rib, is an additional rib that forms above the first rib, resulting from the overgrowth of the transverse proce...
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract Introduction Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
Abnormal immunity of non-survivors with COVID-19: predictors for mortality
Abnormal immunity of non-survivors with COVID-19: predictors for mortality
Abstract Background The outbreak of coronavirus disease 2019 (COVID-19) has rapidly spread all over the world. The specific information about immunity of non-survivors with...
Gender difference in vulnerability and geriatric syndromes among elderly cancer survivors.
Gender difference in vulnerability and geriatric syndromes among elderly cancer survivors.
9091 Background: Few studies have evaluated the gender difference of vulnerability and geriatric syndromes (GS) among cancer survivors. Methods: Using 2003 Medicare Current Benefi...

Back to Top